Naomi Hunder Silverback Therapeutics, Inc. (SBTX) insider trading activity
Naomi Hunder is Chief Medical Officer of Silverback Therapeutics, Inc.. Currently has a direct ownership of 54,427 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on May 02, 2022, when has been sold 43,177 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
54.4K
0%
3M change
0%
12M change
Total Value Held
$0
NH
Naomi Hunder
Chief Medical Officer
Seattle, WA